The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Depletion of Cd4+ T Cells Causes Reactivation of Murine Persistent Tuberculosis despite Continued Expression of Interferon γ and Nitric Oxide Synthase 2
Open accessAbstract
Tuberculosis is a major cause of death in much of the world. Current estimates are that one-third of the world's population is infected with Mycobacterium tuberculosis. Most infected persons control the infection but in many cases may not eliminate the organism. Reactivation of this clinically latent infection is responsible for a large proportion of active tuberculosis cases. A major risk factor for reactivation of latent tuberculosis is HIV infection, suggesting a role for the CD4+ T cell subset in maintaining the latent persistent infection. In this study, we tested the requirement for CD4+ T cells in preventing reactivation in a murine model of latent tuberculosis. Antibody-mediated depletion of CD4+ T cells resulted in rapid reactivation of a persistent infection, with dramatically increased bacterial numbers in the organs, increased pathology in the lungs, and decreased survival. Although CD4+ T cells are believed to be a major source of interferon (IFN)-γ, expression of the gene for IFN-γ in the lungs of CD4+ T cell–depleted mice was similar to that in control mice. In addition, inducible nitric oxide synthase production and activity was unimpaired after CD4+ T cell depletion, indicating that macrophage activation was present even during CD4+ T cell deficiency. These data indicate that CD4+ T cells are necessary to prevent reactivation but may have roles in addition to IFN-γ production and macrophage activation in controlling a persistent tuberculous infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection.
Flynn, J. L., Chan, J., Triebold, K. J., Dalton, D. K., Stewart, T. A., & Bloom, B. R. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2249 · Cited by 2,465
Self-citationDisseminated tuberculosis in interferon gamma gene-disrupted mice.
Cooper, A. M., Dalton, D. K., Stewart, T. A., Griffin, J. P., Russell, D. G., & Orme, I. M. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.6.2243 · Cited by 1,986
Multiple Defects of Immune Cell Function in Mice with Disrupted Interferon-γ Genes
Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., & Stewart, T. A. (1993) · Science · doi:10.1126/science.8456300 · Cited by 1,727
Macrophage deactivation by interleukin 10.
Bogdan, C., Vodovotz, Y., & Nathan, C. (1991) · The Journal of experimental medicine · doi:10.1084/jem.174.6.1549 · Cited by 1,238
Identification of nitric oxide synthase as a protective locus against tuberculosis
MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.5243 · Cited by 1,180
An Antimicrobial Activity of Cytolytic T Cells Mediated by Granulysin
Stenger, S., Hanson, D. A., Teitelbaum, R., Dewan, P., Niazi, K. R., Froelich, C. J., Ganz, T., Thoma-Uszynski, S., Melián, A., Bogdan, C., et al. (1998) · Science · doi:10.1126/science.282.5386.121 · Cited by 1,065
Deactivation of macrophages by transforming growth factor-β
Tsunawaki, S., Sporn, M., Ding, A., & Nathan, C. (1988) · Nature · doi:10.1038/334260a0 · Cited by 861
Gazzinelli, R. T., Hieny, S., Wynn, T. A., Wolf, S., & Sher, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6115 · Cited by 835
Host factors and the pathogenesis of HIV-induced disease
Fauci, A. S. (1996) · Nature · doi:10.1038/384529a0 · Cited by 829
Global Epidemiology of Tuberculosis: Morbidity and Mortality of a Worldwide Epidemic
Raviglione, M. C. (1995) · JAMA · doi:10.1001/jama.1995.03520270054031 · Cited by 811
Flynn, J. L., Goldstein, M. M., Triebold, K. J., Koller, B., & Bloom, B. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12013 · Cited by 792
Self-citationBennett, S. R. M., Carbone, F. R., Karamalis, F., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.1.65 · Cited by 725
Scharton, T. M., & Scott, P. (1993) · The Journal of experimental medicine · doi:10.1084/jem.178.2.567 · Cited by 608
Differential Effects of Cytolytic T Cell Subsets on Intracellular Infection
Stenger, S., Mazzaccaro, R. J., Uyemura, K., Cho, S., Barnes, P. F., Rosat, J.-P., Sette, A., Brenner, M. B., Porcelli, S. A., Bloom, B. R., et al. (1997) · Science · doi:10.1126/science.276.5319.1684 · Cited by 519
Helper activity is required for the in vivo generation of cytotoxic T lymphocytes
Keene, J.-A., & Forman, J. (1982) · The Journal of Experimental Medicine · doi:10.1084/jem.155.3.768 · Cited by 500
Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis.
Nicholson, S., Bonecini-Almeida, M. D. G., Lapa e Silva, J. R., Nathan, C., Xie, Q. W., Mumford, R., Weidner, J. R., Calaycay, J., Geng, J., Boechat, N., et al. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.5.2293 · Cited by 496
Caruso, A. M., Serbina, N. V., Klein, E. C., Triebold, K. J., Bloom, B. R., & Flynn, J. L. (1999) · PubMed · Cited by 489
Self-citationCD8+ T cells clear influenza virus by perforin or Fas-dependent processes
Topham, D. J., Tripp, R. A., & Doherty, P. C. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.11.5197 · Cited by 486
Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development
Loken, M., Shah, V., Dattilio, K., & Civin, C. (1987) · Blood · doi:10.1182/blood.v70.5.1316.1316 · Cited by 442
Caruso, A. M., Serbina, N., Klein, E., Triebold, K., Bloom, B. R., & Flynn, J. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.9.5407 · Cited by 418
Self-citationTuberculosis: Pathogenesis, protection, and control
De Cock, K. M. (1995) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(95)90122-1 · Cited by 417
Activated T cells induce interleukin‐12 production by monocytes via CD40‐CD40 ligand interaction
Shu, U., Kiniwa, M., Wu, C. Y., Maliszewski, C., Vezzio, N., Hakimi, J., Gately, M., & Delespesse, G. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250442 · Cited by 414
Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis
Chan, J., Tanaka, K., Carroll, D., Flynn, J., & Bloom, B. R. (1995) · Infection and Immunity · doi:10.1128/iai.63.2.736-740.1995 · Cited by 407
Self-citationHuman cytolytic and interferon γ-secreting CD8+T lymphocytes specific for Mycobacterium tuberculosis
Lalvani, A., Brookes, R., Wilkinson, R. J., Malin, A. S., Pathan, A. A., Andersen, P., Dockrell, H., Pasvol, G., & Hill, A. V. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.270 · Cited by 361
Ottenhoff, T. H. M., Kumararatne, D., & Casanova, J.-L. (1998) · Immunology Today · doi:10.1016/s0167-5699(98)01321-8 · Cited by 324
CD19 Antigen in Leukemia and Lymphoma Diagnosis and Immunotherapy
Scheuermann, R. H., & Racila, E. (1995) · Leukemia & Lymphoma · doi:10.3109/10428199509059636 · Cited by 323
CD40 Ligand Is Required for Protective Cell-Mediated Immunity to Leishmania major
Campbell, K. A., Ovendale, P. J., Kennedy, M. K., Fanslow, W. C., Reed, S. G., & Maliszewski, C. R. (1996) · Immunity · doi:10.1016/s1074-7613(00)80436-7 · Cited by 321
Soong, L., Xu, J.-C., Grewal, I. S., Kima, P., Sun, J., Longley, B. J., Ruddle, N. H., McMahon-Pratt, D., & Flavell, R. A. (1996) · Immunity · doi:10.1016/s1074-7613(00)80434-3 · Cited by 303
Kamanaka, M., Yu, P., Yasui, T., Yoshida, K., Kawabe, T., Horii, T., Kishimoto, T., & Kikutani, H. (1996) · Immunity · doi:10.1016/s1074-7613(00)80435-5 · Cited by 294
Müller, I., Cobbold, S. P., Waldmann, H., & Kaufmann, S. H. (1987) · Infection and Immunity · doi:10.1128/iai.55.9.2037-2041.1987 · Cited by 286
von Herrath, M. G., Yokoyama, M., Dockter, J., Oldstone, M. B., & Whitton, J. L. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1072-1079.1996 · Cited by 279
Rhoades, E. R., Frank, A. A., & Orme, I. M. (1997) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(97)90016-2 · Cited by 277
Helper T cells without CD4: control of leishmaniasis in CD4-deficient mice
Locksley, R., Reiner, S., Hatam, F., Littman, D., & Killeen, N. (1993) · Science · doi:10.1126/science.8367726 · Cited by 268
Reactivation of Latent Tuberculosis: Variations on the Cornell Murine Model
Scanga, C. A., Mohan, V. P., Joseph, H., Yu, K., Chan, J., & Flynn, J. L. (1999) · Infection and Immunity · doi:10.1128/iai.67.9.4531-4538.1999 · Cited by 243
Self-citationAdoptive protection of the Mycobacterium tuberculosis-infected lung
Orme, I. M., & Collins, F. M. (1984) · Cellular Immunology · doi:10.1016/0008-8749(84)90082-0 · Cited by 228
Tascon, R. E., Stavropoulos, E., Lukacs, K. V., & Colston, M. J. (1998) · Infection and Immunity · doi:10.1128/iai.66.2.830-834.1998 · Cited by 228
(2002) · Springer eBooks · doi:10.1007/b111485 · Cited by 224
Ladel, C. H., Daugelat, S., & Kaufmann, S. H. E. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250211 · Cited by 223
Effects of Aminoguanidine on Latent Murine Tuberculosis
Flynn, J. L., Scanga, C. A., Tanaka, K. E., & Chan, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1796 · Cited by 217
Self-citationGlatman-Freedman, A., & Casadevall, A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.3.514 · Cited by 215
Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis
Fenton, M. J., Vermeulen, M. W., Kim, S., Burdick, M., Strieter, R. M., & Kornfeld, H. (1997) · Infection and Immunity · doi:10.1128/iai.65.12.5149-5156.1997 · Cited by 214
Stead, W. W. (1967) · PubMed · doi:10.1164/arrd.1967.95.5.729 · Cited by 206
Macrophages are a significant source of type 1 cytokines during mycobacterial infection
Wang, J., Wakeham, J., Harkness, R., & Xing, Z. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6224 · Cited by 196
Serbina, N. V., & Flynn, J. L. (1999) · Infection and Immunity · doi:10.1128/iai.67.8.3980-3988.1999 · Cited by 174
Self-citationIncrease of tuberculous infection in the organs of B cell-deficient mice
Vordermeier, H. M., Venkataprasad, N., Harris, D. P., & Ivanyi, J. (2003) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1996.d01-845.x · Cited by 167
Lewinsohn, D. M., Alderson, M. R., Briden, A. L., Riddell, S. R., Reed, S. G., & Grabstein, K. H. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.10.1633 · Cited by 165
Serbina, N. V., Liu, C.-C., Scanga, C. A., & Flynn, J. L. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.1.353 · Cited by 164
Self-citationBonecini-Almeida, M. D. G., Chitale, S., Boutsikakis, I., Geng, J., Doo, H., He, S., & Ho, J. L. (1998) · PubMed · Cited by 138
Tian, L., Noelle, R. J., & Lawrence, D. A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250152 · Cited by 130
Immune Mechanisms of Protection
Chan, J., & Kaufmann, S. H. E. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch24 · Cited by 123
Self-citationBonecini-Almeida, M. D. G., Chitale, S., Boutsikakis, I., Geng, J., Doo, H., He, S., & Ho, J. L. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4490 · Cited by 114
Elkins, K., Bosio, C., & Rhinehart-Jones, T. (1999) · Infection and Immunity · doi:10.1128/iai.67.11.6002-6007.1999 · Cited by 112
The Rising Age of the Tuberculosis Patient: A Sign of Success and Failure
Powell, K. E., & Farer, L. S. (1980) · The Journal of Infectious Diseases · doi:10.1093/infdis/142.6.946 · Cited by 95
Adams, L. B., Mason, C. M., Kolls, J. K., Scollard, D. M., Krahenbuhl, J. L., & Nelson, S. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.400 · Cited by 91
Mycobacterium tuberculosis aerogenic rechallenge infections in B cell-deficient mice
Johnson, C. M., Cooper, A. M., Frank, A. A., Bonorino, C., Wysocki, L. J., & Orme, I. M. (1997) · Tubercle and Lung Disease · doi:10.1016/s0962-8479(97)90006-x · Cited by 89
Campos‐Neto, A., Ovendale, P. J., Bement, T., Koppi, T. A., Fanslow, W. C., Rossi, M. A., & Alderson, M. R. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.5.2037 · Cited by 80
Campos‐Neto, A., Ovendale, P. J., Bement, T., Koppi, T. A., Fanslow, W. C., Rossi, M. A., & Alderson, M. R. (1998) · PubMed · Cited by 78
Hänsch, H. C. R., Smith, D. A., Mielke, M. E. A., Hahn, H. H., Bancroft, G. J., & Ehlers, S. (1996) · International Immunology · doi:10.1093/intimm/8.8.1299 · Cited by 71
Müller, H., & Krüger, S. (1994) · Immunobiology · doi:10.1016/s0171-2985(11)80441-9 · Cited by 51
Cited by
Nitric oxide and the immune response
Bogdan, C. (2001) · Nature Immunology · doi:10.1038/ni1001-907 · Cited by 3,447
Flynn, J. L., & Chan, J. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.93 · Cited by 2,155
Self-citationRegulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin
Sherman, D. R., Voskuil, M., Schnappinger, D., Liao, R., Harrell, M. I., & Schoolnik, G. K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121172498 · Cited by 729
North, R. J., & Jung, Y.-J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104635 · Cited by 677
Bafica, A., Scanga, C. A., Feng, C. G., Leifer, C., Cheever, A., & Sher, A. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20051782 · Cited by 601
Metadata
- Authors
- Scanga, C. A., Mohan, V. P., Yu, K., Joseph, H., Tanaka, K., Chan, J., & Flynn, J. L.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2000-07-31
- Volume
- 192
- Issue
- 3
- Pages
- 347-358
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2135437388
- Cited by
- 350
- References
- 59
- FWCI
- 15.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.